English | Español
Patient Daily | Feb 4, 2026

Griffith University study finds reduced brain connectivity in ME/CFS and Long COVID patients
Patient Daily | Feb 4, 2026

Study links reduced oral microbiota diversity to poorer cognition in schizophrenia
Patient Daily | Feb 4, 2026

Genetic disorder diagnosed in prehistoric Italian burial through ancient DNA analysis
Patient Daily | Feb 4, 2026

Ischemic stroke doubles risk for recurrence during or soon after pregnancy
Patient Daily | Feb 4, 2026

Researchers identify blood biomarkers for early diagnosis of Parkinson’s disease
Patient Daily | Feb 4, 2026

Study finds statins may boost effectiveness of cancer immunotherapy
Patient Daily | Feb 4, 2026

Study finds higher dementia risk linked to cerebral amyloid angiopathy
Patient Daily | Feb 4, 2026

Study finds brain stimulation boosts focus but heightens threat response in depressed patients

Trending
+ Pharmaceuticals
Patient Daily | Feb 3, 2026

Drug Channels President on 340B: 'no one knows where the 340B profits go, or which patients benefit'
+ Pharmaceuticals
Patient Daily | Feb 2, 2026

Clinical trial landscape shifts globally as China increases role in innovation
+ Pharmaceuticals
Patient Daily | Feb 5, 2026

FDA lifts hold on Intellia's phase III ATTR gene editing trial
+ Pharmaceuticals
Patient Daily | Feb 4, 2026

Summit Therapeutics’ ivonescimab faces key FDA decision as potential Keytruda competitor